LONDON (Reuters): Adding radiotherapy to hormone drugs for prostate cancer patients significantly improves survival compared with hormone treatment alone.
The combination could save many lives if it were made standard practice, scientists said on Thursday.
Already a subscriber? Log in
The Star Festive Promo: Get 35% OFF Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
